A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls

BACKGROUND: RA and CVD both have inflammation as part of the underlying biology. Our objective was to explore the relationships of GlycA, a measure of glycosylated acute phase proteins, with inflammation and cardiometabolic risk in RA, and explore whether these relationships were similar to those fo...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Arthritis Res Ther
Auteurs principaux: Bartlett, David B., Connelly, Margery A., AbouAssi, Hiba, Bateman, Lori A., Tune, K. Noelle, Huebner, Janet L., Kraus, Virginia B., Winegar, Deborah A., Otvos, James D., Kraus, William E., Huffman, Kim M.
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2016
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4828830/
https://ncbi.nlm.nih.gov/pubmed/27067270
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-016-0982-5
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires